The remaining 22 (5.3%) individuals had ALT level > 2 × ULN of non‐HBV‐related cause (eg, nonalcoholic fatty liver disease, medication use, malignant infiltration). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.